Call Options

1 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2023

May 19, 2023

BUY
$283.23 - $323.1 $916,815 - $1.05 Million
3,237 New
3,237 $1.02 Billion

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Advanced Portfolio Management, LLC Portfolio

Follow Advanced Portfolio Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advanced Portfolio Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advanced Portfolio Management, LLC with notifications on news.